These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. FOXM1 regulated by ERK pathway mediates TGF-β1-induced EMT in NSCLC. Kong FF, Zhu YL, Yuan HH, Wang JY, Zhao M, Gong XD, Liu F, Zhang WY, Wang CR, Jiang B. Oncol Res; 2014; 22(1):29-37. PubMed ID: 25700356 [Abstract] [Full Text] [Related]
5. miR-671-5p inhibits epithelial-to-mesenchymal transition by downregulating FOXM1 expression in breast cancer. Tan X, Fu Y, Chen L, Lee W, Lai Y, Rezaei K, Tabbara S, Latham P, Teal CB, Man YG, Siegel RS, Brem RF, Fu SW. Oncotarget; 2016 Jan 05; 7(1):293-307. PubMed ID: 26588055 [Abstract] [Full Text] [Related]
6. Decitabine reverses TGF-β1-induced epithelial-mesenchymal transition in non-small-cell lung cancer by regulating miR-200/ZEB axis. Zhang N, Liu Y, Wang Y, Zhao M, Tu L, Luo F. Drug Des Devel Ther; 2017 Jan 05; 11():969-983. PubMed ID: 28405157 [Abstract] [Full Text] [Related]
7. Long non-coding RNA linc00673 regulated non-small cell lung cancer proliferation, migration, invasion and epithelial mesenchymal transition by sponging miR-150-5p. Lu W, Zhang H, Niu Y, Wu Y, Sun W, Li H, Kong J, Ding K, Shen HM, Wu H, Xia D, Wu Y. Mol Cancer; 2017 Jul 11; 16(1):118. PubMed ID: 28697764 [Abstract] [Full Text] [Related]
11. Knockdown of LncRNA-XIST Suppresses Proliferation and TGF-β1-Induced EMT in NSCLC Through the Notch-1 Pathway by Regulation of miR-137. Wang X, Zhang G, Cheng Z, Dai L, Jia L, Jing X, Wang H, Zhang R, Liu M, Jiang T, Yang Y, Yang M. Genet Test Mol Biomarkers; 2018 Jun 11; 22(6):333-342. PubMed ID: 29812958 [Abstract] [Full Text] [Related]
12. MiR-182 inhibits the epithelial to mesenchymal transition and metastasis of lung cancer cells by targeting the Met gene. Li Y, Zhang H, Li Y, Zhao C, Fan Y, Liu J, Li X, Liu H, Chen J. Mol Carcinog; 2018 Jan 11; 57(1):125-136. PubMed ID: 28940757 [Abstract] [Full Text] [Related]
13. TGF-β1-induced epithelial-mesenchymal transition in lung cancer cells involves upregulation of miR-9 and downregulation of its target, E-cadherin. Wang H, Wu Q, Zhang Y, Zhang HN, Wang YB, Wang W. Cell Mol Biol Lett; 2017 Jan 11; 22():22. PubMed ID: 29118814 [Abstract] [Full Text] [Related]
14. Overexpression of FOXM1 is associated with EMT and is a predictor of poor prognosis in non-small cell lung cancer. Kong FF, Qu ZQ, Yuan HH, Wang JY, Zhao M, Guo YH, Shi J, Gong XD, Zhu YL, Liu F, Zhang WY, Jiang B. Oncol Rep; 2014 Jun 11; 31(6):2660-8. PubMed ID: 24715097 [Abstract] [Full Text] [Related]
15. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD, Wei JC, Qu K, Wang ZX, Wu QF, Tai MH, Liu HC, Zhang RY, Liu C. World J Gastroenterol; 2015 Jan 07; 21(1):196-213. PubMed ID: 25574092 [Abstract] [Full Text] [Related]
16. MiR-138 inhibits cell proliferation and reverses epithelial-mesenchymal transition in non-small cell lung cancer cells by targeting GIT1 and SEMA4C. Li J, Wang Q, Wen R, Liang J, Zhong X, Yang W, Su D, Tang J. J Cell Mol Med; 2015 Dec 07; 19(12):2793-805. PubMed ID: 26283050 [Abstract] [Full Text] [Related]
18. Effects of FOXJ2 on TGF-β1-induced epithelial-mesenchymal transition through Notch signaling pathway in non-small lung cancer. Yang Q, Cao X, Tao G, Zhou F, Zhao P, Shen Y, Chen X. Cell Biol Int; 2017 Jan 07; 41(1):79-83. PubMed ID: 27611107 [Abstract] [Full Text] [Related]
19. MiR-9 is involved in TGF-β1-induced lung cancer cell invasion and adhesion by targeting SOX7. Han L, Wang W, Ding W, Zhang L. J Cell Mol Med; 2017 Sep 07; 21(9):2000-2008. PubMed ID: 28266181 [Abstract] [Full Text] [Related]
20. miR-16 mimics inhibit TGF-β1-induced epithelial-to-mesenchymal transition via activation of autophagy in non-small cell lung carcinoma cells. Wang H, Zhang Y, Wu Q, Wang YB, Wang W. Oncol Rep; 2018 Jan 07; 39(1):247-254. PubMed ID: 29138833 [Abstract] [Full Text] [Related] Page: [Next] [New Search]